DexCom Stock Drops as Diabetes Devices Maker Gets FDA Warning Letter
Key Takeaways DexCom received a warning letter from the Food and Drug Administration following inspections of two of its ...
Dexcom (DXCM) Receives a Buy from Piper Sandler
Piper Sandler analyst Matthew O’Brien maintained a Buy rating on Dexcom (DXCM – Research Report) today and set a price target of $100.00. The ...
DexCom (NasdaqGS:DXCM) Shares Dip 1% Despite 7% Sales Growth
DexCom (NasdaqGS:DXCM) recently received a warning letter from the FDA, which pointed out issues in manufacturing processes and quality management. While these regulatory developments did not impact ...
Devdiscourse17h
USDA Scraps Food Safety Committees Amid Oversight Concerns
The U.S. Department of Agriculture has dissolved two key food safety advisory committees, sparking concern over government ...